Citation Impact
Citing Papers
Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)
2014
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
2018
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
Breast cancer
2019 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Breast cancer
2016 Standout
3D modeling, custom implants and its future perspectives in craniofacial surgery
2014
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
2016 Standout
3D-printing techniques in a medical setting: a systematic literature review
2016 Standout
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Mainstreaming genetic testing of cancer predisposition genes
2014
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience
2012
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
2016
3D printing in dentistry
2015 Standout
Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: A review
2016 Standout
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer
2015
ATM Mutations in Cancer: Therapeutic Implications
2016
Breast Cancer Treatment
2019 Standout
A Randomized Phase II Study of Veliparib with Temozolomide Or Carboplatin/Paclitaxel Versus Placebo with Carboplatin/Paclitaxel in Brca1 / 2 Metastatic Breast Cancer: Design and Rationale
2016
Works of Robert Chrzan being referenced
Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer
2012
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs)
2011
Cranioplasty prosthesis manufacturing based on reverse engineering technology
2012